Orally Inhaled and Nasal Drug Products (OINDP) Subcommittee Report to the Advisory Committee for Pharmaceutical Sciences Rockville, Maryland November 15, 2000

12/20/00


Click here to start


Table of Contents

Orally Inhaled and Nasal Drug Products (OINDP) Subcommittee Report to the Advisory Committee for Pharmaceutical Sciences Rockville, Maryland November 15, 2000

Outline

Published OINDP Draft CMC Guidances (Under Revision)

Activities Since Publication of the OINDP Draft Guidances

Dose Content Uniformity

PPT Slide

Summary of Comments on Question A

PPT Slide

Summary of Comments on Question B

Author: CDER User